Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
Clinical trial NCT05974527 · WITHDRAWN
Trial details
- NCT number
- NCT05974527
- Sponsor
- Brigham and Women's Hospital
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2025-09-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.